简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-06-21 16:43 Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction
2021-06-21 16:12 Pattern Computer Develops Accurate 15-Second COVID-19 Test
2021-06-21 09:57 Prestige Biopharma’s First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval for Clinical Trial in France
2021-06-18 14:23 Organon Completes Acquisition of Alydia Health – A Medical Device Company Focused on Postpartum Hemorrhage
2021-06-18 13:40 UVD Robots Selected by Global Facility Management Company ISS to Provide Autonomous Disinfection Robots
2021-06-18 13:31 Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings
2021-06-18 11:51 Wipro joins World Economic Forum’s Partnership for New Work Standards initiative
2021-06-16 19:01 Diabetes Center Berne Launches Its First Open Innovation Challenge and Supports the Most Promising Ideas Submitted With Coaching, Expertise and a Total of 200,000 USD in Funding
2021-06-16 18:50 Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment
2021-06-16 15:54 Alentis Therapeutics Raises USD 67 Million in Series B Financing
2021-06-16 10:12 New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
2021-06-15 14:41 Children's Hospital Los Angeles Delivers the Best Care for Kids in the Pacific U.S., and a No. 5 National Ranking, for Third Year in a Row
2021-06-15 14:13 Amazon and National Safety Council Create First-of-its-Kind Partnership to Solve the Most Common Workplace Injury in the U.S.
2021-06-15 10:37 Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
2021-06-11 09:43 ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
2021-06-10 18:24 Safeguard DNA Diagnostics Launches Rhinostics Dry Collection Swabs for COVID Testing as Primary Collection Devices for Its Laboratories in the Philippines
2021-06-10 10:41 Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations
2021-06-09 18:13 Self Esteem Brands Acquires Digital Nutrition Coaching Brand Stronger U
2021-06-09 16:35 Cardiac Insight Announces Expansion Into More Than 20 Asia-Pacific Markets with i.SigNal by Dreamtech Partnership
2021-06-09 10:35 Agendia’s MammaPrint® Test is the First to Demonstrate the Ability to Predict Benefit from Extended Endocrine Treatment in NSABP B-42 Trial

Business Wire Weibo

Press Releases

Latest Releases